title: Subcutaneous continuous erythropoietin receptor activator conversion provides practical advantages and potential convenience for peritoneal dialysis patients.
authors: School of Medicine, Chang Gung University, Keelung, Taiwan.
authors: Chun-Yu
authors: CY
authors: Chen
authors: Heng-Jung
authors: HJ
authors: Hsu
authors: Yu-Ying
authors: YY
authors: Lin
authors: Mai-Szu
authors: MS
authors: Wu
mesh_terms: D000328:Adult; D000368:Aged; D000740:Anemia / Q000209:etiology / Q000517:prevention & control*; D004921:Erythropoietin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000009:adverse effects; D011092:Polyethylene Glycols / Q000008:administration & dosage*; D011446:Prospective Studies
chemical_list: C508420:continuous erythropoietin receptor activator; D004921:Erythropoietin; D011092:Polyethylene Glycols